Northway Biotech, a biopharmaceutical contract development and manufacturing organisation (CDMO), has broadened its service portfolio to include Viral Clearance Studies (VCS), supporting both gene therapy and protein-based drug development. The announcement follows the opening of the company’s new Gene Therapy
Micreos Pharmaceuticals AG has entered into a strategic partnership with Northway Biotech, a Contract Development and Manufacturing Organization (CDMO), to advance the cGMP manufacturing of its biologic therapeutic, MEndoB. The investigational drug, a first-in-class dual-active domain targeted medicine, is set to enter clinical
Mallia Therapeutics, a biopharmaceutical company focusing on hair loss treatments, has formed a strategic collaboration with Northway Biotech (NBT), a biologics Contract Development and Manufacturing Organization (CDMO), to scale up production of its soluble CD83 protein (sCD83). The partnership aims
Northway Biotech is a CMO/CDMO, Biopharmaceutical company company operating in the pharmaceutical industry. Northway Biotech is an end-to-end contract development and manufacturing organization (CDMO) supporting customers worldwide. The company’s wide-ranging expertise and vertically integrated service offering translate to the ability
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
